文献速递临床试验与 GCP新药、器械与细胞基因治疗研发

苦杏仁(Amygdalus communis L. var. Amara)胶作为功能性食品对2型糖尿病女性代谢指标、炎症标志物及心理健康的影响:一项盲法随机对照试验方案

The effect of bitter almond (Amygdalus communis L. var. Amara) gum as a functional food on metabolic profile, inflammatory markers, and mental health in type 2 diabetes women: a blinded randomized controlled trial protocol.
PubMed 文献 · Trials · 2023-01-17

本方案计划开展一项随机、三盲、安慰剂对照试验,纳入44名2型糖尿病女性,随机分为干预组(n=20)和安慰剂组(n=20),分别接受苦杏仁胶5 g/d或安慰剂,持续8周。将在基线和研究结束时测量血糖指标、血脂谱、炎症标志物、氧化应激指标、色氨酸、犬尿氨酸、皮质醇、GLP-1、瘦素、脂联素、胃饥饿素、PPAR基因表达、BDNF、内皮细胞黏附分子、纤溶酶原、CD4、CD8、人体测量指标、血压、膳食摄入及心理健康,以评估苦杏仁胶作为功能性食品的获益。

要点

  • 计划纳入44名2型糖尿病女性,随机分为干预组(n=20)和安慰剂组(n=20),分别接受苦杏仁胶5 g/d或安慰剂,持续8周。
  • 将在基线和研究结束时测量血糖指标、血脂谱、炎症标志物、氧化应激指标、色氨酸、犬尿氨酸、皮质醇、GLP-1、瘦素、脂联素、胃饥饿素、PPAR基因表达、BDNF、内皮细胞黏附分子、纤溶酶原、CD4、CD8、人体测量指标、血压、膳食摄入及心理健康。
  • 统计采用SPSS软件(版本24),P值小于0.05视为有统计学显著性。

核心结论

  • 本随机对照试验将旨在探究苦杏仁胶补充对2型糖尿病女性心血管代谢、免疫炎症及氧化应激生物标志物以及心理健康的任何有益效应。

研究设计与样本

  • 随机、三盲、安慰剂对照试验方案。
  • 计划纳入44名2型糖尿病女性,随机分配至干预组(n=20)和安慰剂组(n=20)。

关键数值与推荐

  • 计划干预组接受苦杏仁胶5 g/d,安慰剂组接受安慰剂,持续8周。
  • 统计采用SPSS软件(版本24),P值小于0.05视为有统计学显著性。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Using functional foods in the prevention and treatment of type 2 diabetes mellitus (T2DM) has increased across the world owing to their availability, cultural acceptability, and lower side effects. The present study will aim to examine the impact of bitter almond (Amygdalus communis L. var. Amara) gum as a functional food on metabolic profile, inflammatory markers, and mental health in women with T2DM. METHODS: We will conduct a randomized, triple-blind, placebo-controlled trial. A total of 44 women with T2DM will be randomly allocated into two groups: an intervention group (n = 20) and a placebo group (n = 20). Patients will receive either 5 g/d of bitter melon gum or a placebo for 8 weeks. Clinical and biochemical outcome parameters which include glycemic indices, lipid profile, inflammatory markers, oxidative stress indices, tryptophan (Trp), kynurenine (KYN), cortisol, glucagon-like peptide 1 (GLP-1), leptin, adiponectin, ghrelin, peroxisome proliferator-activated receptor (PPAR) gene expression, brain-derived neurotrophic factor (BDNF), endothelial cell adhesion molecules, plasminogen, cluster deference 4 (CD4), cluster deference 8 (CD8), anthropometric indices, blood pressure, dietary intake, and mental health will be measured at the baseline and end of the study. Statistical analysis will be conducted using the SPSS software (version 24), and P value less than 0.05 will be considered statistically significant. DISCUSSION: The present randomized controlled trial will aim to investigate any beneficial effects of bitter almond gum supplementation on the cardio-metabolic, immune-inflammatory, and oxidative stress biomarkers, as well as mental health in women with T2DM. ETHICS AND DISSEMINATION: The study protocol was approved by the Ethical Committee of the Tabriz University of Medical Sciences (IR.TBZMED.REC.1399.726). TRIAL REGISTRATION: Iranian Registry of Clinical Trials ( www.irct.ir/IRCT20150205020965N7 ).

来源:Trials,查看原文。版权归原作者所有。

引用

  1. Saati S, Dehghan P, Azizi-Soleiman F, et al. The effect of bitter almond (Amygdalus communis L. var. Amara) gum as a functional food on metabolic profile, inflammatory markers, and mental health in type 2 diabetes women: a blinded randomized controlled trial protocol. Trials. 2023. PMID: 36650599. doi:10.1186/s13063-023-07085-7

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。